PL1732931T3 - Sposoby otrzymywania (3R,3aS,6aR) heksahydro-furo[2,3-b]furan-3-olu - Google Patents

Sposoby otrzymywania (3R,3aS,6aR) heksahydro-furo[2,3-b]furan-3-olu

Info

Publication number: PL1732931T3
Authority: PL; Poland
Prior art keywords: furo; hexahydro; furan; preparation; methods
Prior art date: 2004-03-31

Application number

PL05729507.3T

Other languages

English (en)

Inventor

Peter Jan Leonard Mario Quaedflieg

Bart Rudolf Romanie Kesteleyn

Robert Jan Vijn

Constantinus Simon Maria Liebregts

Jacob Hermanus Matheus Hero Kooistra

Franciscus Alphons Marie Lommen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-31

Filing date

2005-03-31

Publication date

2016-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34928933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1732931(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-03-31 Application filed filed Critical

2016-11-30 Publication of PL1732931T3 publication Critical patent/PL1732931T3/pl

Links

RCDXYCHYMULCDZ-HCWXCVPCSA-N (3as,4r,6ar)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-ol Chemical compound O1CC[C@H]2[C@@H](O)CO[C@H]21 RCDXYCHYMULCDZ-HCWXCVPCSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Furan Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polyesters Or Polycarbonates (AREA)

PL05729507.3T 2004-03-31 2005-03-31 Sposoby otrzymywania (3R,3aS,6aR) heksahydro-furo[2,3-b]furan-3-olu PL1732931T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04101336		2004-03-31

Publications (1)

Publication Number	Publication Date
PL1732931T3 true PL1732931T3 (pl)	2016-11-30

Family

ID=34928933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05729507.3T PL1732931T3 (pl)	2004-03-31	2005-03-31	Sposoby otrzymywania (3R,3aS,6aR) heksahydro-furo[2,3-b]furan-3-olu

Country Status (28)

Country	Link
US (1)	US7595408B2 (pl)
EP (1)	EP1732931B1 (pl)
JP (1)	JP4778955B2 (pl)
KR (1)	KR101135156B1 (pl)
CN (1)	CN1938316B (pl)
AP (1)	AP2528A (pl)
AU (1)	AU2005229435B2 (pl)
BR (1)	BRPI0509514B1 (pl)
CA (1)	CA2559959C (pl)
CY (1)	CY1119150T1 (pl)
DK (1)	DK1732931T3 (pl)
ES (1)	ES2587571T3 (pl)
HR (1)	HRP20161031T1 (pl)
HU (1)	HUE029886T2 (pl)
IL (1)	IL178019A (pl)
LT (1)	LT1732931T (pl)
ME (1)	ME02525B (pl)
NO (1)	NO338175B1 (pl)
NZ (1)	NZ549971A (pl)
PL (1)	PL1732931T3 (pl)
PT (1)	PT1732931T (pl)
RS (1)	RS55011B1 (pl)
RU (1)	RU2421458C2 (pl)
SI (1)	SI1732931T1 (pl)
TW (1)	TWI383975B (pl)
UA (1)	UA100835C2 (pl)
WO (1)	WO2005095410A1 (pl)
ZA (1)	ZA200609008B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RS51675B (sr)	2006-11-09	2011-10-31	Tibotec Pharmaceuticals	Metode za dobivanje heksahidrofuro[2,3-b]furan-3-ola
CN101024646B (zh) *	2007-02-06	2010-07-14	启东东岳药业有限公司	4-甲氧基呋喃并呋喃-2-酮的纯化方法
WO2008132154A1 (en)	2007-04-27	2008-11-06	Tibotec Pharmaceuticals Ltd.	Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
WO2009030733A1 (en) *	2007-09-04	2009-03-12	Dsm Ip Assets B.V.	Method for the synthesis of 4-alkoxy-, 4-hydroxy- and 4-aryloxy-substituted tetrahydro-furo[3,4-b]furan-2(3h)-one compounds
WO2010120273A2 (en)	2008-12-03	2010-10-21	Massachusetts Institute Of Technology	Multifunctional composites based on coated nanostructures
US8921415B2 (en)	2009-01-29	2014-12-30	Mapi Pharma Ltd.	Polymorphs of darunavir
BR112012009956A2 (pt)	2009-10-30	2015-09-29	Lupin Ltd	um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula.
PL2528923T3 (pl)	2010-01-28	2015-01-30	Mapi Pharma Ltd	Sposób wytwarzania darunawiru i pochodnych darunawiru
EP3795572B1 (en)	2012-07-24	2023-11-15	Laurus Labs Limited	Darunavir propionate solvate
CN103864813B (zh) *	2012-12-18	2017-02-22	上海迪赛诺化学制药有限公司	一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法
CN104628552A (zh) *	2015-02-09	2015-05-20	许昌豪丰化学科技有限公司	一种新淬灭体系及其应用
WO2017041228A1 (zh) *	2015-09-08	2017-03-16	浙江九洲药业股份有限公司	六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
EP3532478B1 (en)	2016-10-27	2021-05-26	Gilead Sciences, Inc.	Crystalline form of darunavir free base
CN110272398B (zh)	2018-03-16	2022-11-29	江苏瑞科医药科技有限公司	六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
CN120405821A (zh)	2019-02-15	2025-08-01	迪吉伦斯公司	使用集成光栅提供全息波导显示的方法和装置
CN115557964A (zh) *	2022-10-18	2023-01-03	启东东岳药业有限公司	一种药物化合物的制备方法
CN117659033B (zh) *	2023-12-05	2026-01-13	南京杰运医药科技有限公司	一种地瑞那韦中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0427693A1 (en) *	1989-10-11	1991-05-15	Monsanto Company	Method for azide displacement of alpha-triflates of 1,5-lactones
ES2127938T3 (es)	1993-08-24	1999-05-01	Searle & Co	Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas.
MX9603909A (es)	1994-03-07	1997-03-29	Vertex Pharma	Derivados de sulfonamida como inhibidores de proteasa aspartilo.
IN188837B (pl) *	1998-05-22	2002-11-09	Torrent Pharmaceuticals Ltd
BR9912169A (pt)	1998-06-19	2001-04-10	Vertex Pharma	Inibidores de sulfonamida de protease de aspartil
PT2336134T (pt)	1998-06-23	2016-10-19	The Board Of Trustees Of The Univ Of Illionis	Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
EP1159278B1 (en)	1999-02-12	2005-11-30	Vertex Pharmaceuticals Incorporated	Inhibitors of aspartyl protease
AR031520A1 (es)	1999-06-11	2003-09-24	Vertex Pharma	Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
CA2386850C (en)	1999-10-06	2010-03-30	Piet Tom Bert Paul Wigerinck	Hexahydrofuro[2,3-b]furan-3-yl-n-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor
CN100519561C (zh) *	2001-09-10	2009-07-29	泰博特克药品有限公司	制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法

2005
- 2005-03-30 TW TW094109909A patent/TWI383975B/zh not_active IP Right Cessation
- 2005-03-31 ME MEP-2016-164A patent/ME02525B/me unknown
- 2005-03-31 UA UAA200610289A patent/UA100835C2/ru unknown
- 2005-03-31 PL PL05729507.3T patent/PL1732931T3/pl unknown
- 2005-03-31 US US10/599,497 patent/US7595408B2/en not_active Expired - Lifetime
- 2005-03-31 KR KR1020067022232A patent/KR101135156B1/ko not_active Expired - Lifetime
- 2005-03-31 CA CA2559959A patent/CA2559959C/en not_active Expired - Lifetime
- 2005-03-31 CN CN200580010400XA patent/CN1938316B/zh not_active Expired - Lifetime
- 2005-03-31 AP AP2006003748A patent/AP2528A/xx active
- 2005-03-31 EP EP05729507.3A patent/EP1732931B1/en not_active Expired - Lifetime
- 2005-03-31 HR HRP20161031TT patent/HRP20161031T1/hr unknown
- 2005-03-31 WO PCT/EP2005/051452 patent/WO2005095410A1/en not_active Ceased
- 2005-03-31 ES ES05729507.3T patent/ES2587571T3/es not_active Expired - Lifetime
- 2005-03-31 JP JP2007505559A patent/JP4778955B2/ja not_active Expired - Lifetime
- 2005-03-31 SI SI200532087A patent/SI1732931T1/sl unknown
- 2005-03-31 LT LTEP05729507.3T patent/LT1732931T/lt unknown
- 2005-03-31 BR BRPI0509514-0A patent/BRPI0509514B1/pt not_active IP Right Cessation
- 2005-03-31 PT PT57295073T patent/PT1732931T/pt unknown
- 2005-03-31 AU AU2005229435A patent/AU2005229435B2/en not_active Expired
- 2005-03-31 RU RU2006138228/04A patent/RU2421458C2/ru active
- 2005-03-31 HU HUE05729507A patent/HUE029886T2/en unknown
- 2005-03-31 NZ NZ549971A patent/NZ549971A/en not_active IP Right Cessation
- 2005-03-31 RS RS20160675A patent/RS55011B1/sr unknown
- 2005-03-31 DK DK05729507.3T patent/DK1732931T3/en active
2006
- 2006-09-11 IL IL178019A patent/IL178019A/en active IP Right Grant
- 2006-10-30 ZA ZA200609008A patent/ZA200609008B/xx unknown
- 2006-10-31 NO NO20064977A patent/NO338175B1/no unknown
2016
- 2016-08-17 CY CY20161100809T patent/CY1119150T1/el unknown

Also Published As

Publication number	Publication date
TWI383975B (zh)	2013-02-01
BRPI0509514B1 (pt)	2022-09-27
RU2421458C2 (ru)	2011-06-20
US7595408B2 (en)	2009-09-29
CA2559959C (en)	2013-11-19
IL178019A (en)	2014-02-27
IL178019A0 (en)	2006-12-31
BRPI0509514A8 (pt)	2016-02-10
RU2006138228A (ru)	2008-05-10
DK1732931T3 (en)	2016-08-29
CN1938316B (zh)	2012-12-12
KR101135156B1 (ko)	2012-04-23
JP4778955B2 (ja)	2011-09-21
CA2559959A1 (en)	2005-10-13
NZ549971A (en)	2010-12-24
BRPI0509514A (pt)	2007-09-11
WO2005095410A1 (en)	2005-10-13
TW200602346A (en)	2006-01-16
JP2007530638A (ja)	2007-11-01
NO338175B1 (no)	2016-08-01
ES2587571T3 (es)	2016-10-25
CN1938316A (zh)	2007-03-28
SI1732931T1 (sl)	2016-10-28
AU2005229435A1 (en)	2005-10-13
US20070208184A1 (en)	2007-09-06
ME02525B (me)	2017-02-20
NO20064977L (no)	2006-10-31
CY1119150T1 (el)	2018-01-10
AP2006003748A0 (en)	2006-10-31
LT1732931T (lt)	2016-09-12
AP2528A (en)	2012-12-10
PT1732931T (pt)	2016-07-14
EP1732931A1 (en)	2006-12-20
KR20070026479A (ko)	2007-03-08
ZA200609008B (en)	2008-07-30
HRP20161031T1 (hr)	2016-10-21
AU2005229435B2 (en)	2011-07-07
EP1732931B1 (en)	2016-05-18
RS55011B1 (sr)	2016-11-30
UA100835C2 (ru)	2013-02-11
HUE029886T2 (en)	2017-04-28

Publication	Publication Date	Title
IL194122A (en)	2016-08-31	Process for making (6ar, 3as, 3r) hexahydroporo [3,2– b] furan – 3 – val
WO2008055970A3 (en)	2008-06-26	Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol
AP2528A (en)	2012-12-10	Methods for the preparation of (3R,3aS,6aR) hexahydro- furo [2,3-b] furan-3-ol
HUP0402140A3 (en)	2007-05-29	Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol
IL211191A (en)	2015-07-30	Oxalate salt of (3as, 4r, 6s, 6ar) –6– (2– hydroxyethoxy) –2,2 – dimethyl tetrahydro –3 ah– cyclopenta [d] [1,3] dioxol – 4 – amine
ZA201202025B (en)	2022-03-30	INTERMEDIATES USEFUL IN THE PREPARATION OF PYRROLO[2,3-b] PYRIDINE DERIVATIVES
TWI365189B (en)	2012-06-01	Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives
IL186354A0 (en)	2008-01-20	INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF TRANS -5-CHLORO-2-METHYL-2,3,3a,12b-TETRAHYDRO-1H -DIBENZ[2,3:6,7] OXEPINO [4,5-c] PYRROLE
IL182177A0 (en)	2007-07-24	Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
ZA200702541B (en)	2008-09-25	Process for preparing 4,5-dihydro-pyrazolo [3,4-c]pyrid-2-ones
AU2003287038A8 (en)	2004-05-04	Method of preparing (3r, 3as, 6ar) -3- hydroxyhexahydrofuro (2, 3-b) furan and related compounds
IL234772A0 (en)	2014-11-30	History of 6-(4-(1-amino-3-hydroxycyclobutyl)phenyl)-5-phenyl(furo, thiano or pyrrolo)[3,2-d]pyrimidin-4-one for cancer treatment
PL1678182T3 (pl)	2007-05-31	Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn
SMT201500309B (it)	2016-01-08	Procedimento per la preparazione di benzil [(3as,4r,6s,6ar)-6-idrossi-2,2-dimetiltetraidro-3ahciclopenta[d][1,3]diossol]-4-il]carbammato ed intermedi nel procedimento
PT2643326T (pt)	2016-12-23	Processo para a preparação de (3r,3as,6ar)-hexa-hidrofuro[2,3-b]furan-3-ol
IL189395A (en)	2015-09-24	Processes for making imidazo [2,1– b] pyridazine-3 – il sulfonyl chloride and sulfonamide history
HK1118045A (en)	2009-01-30	2-heteroaryl-pyrazolo-[4, 3-e]-1, 2, 4-triazolo-[1,5-c]-pyrimidine as adenosine a2a receptor antagonists
HK1102925A (en)	2007-12-07	Process for preparing 4,5-dihydro-pyrazolo [3,4-c]pyrid-2-ones